Evaluation of assay technologies for the identification of protein-peptide interaction antagonists

Assay and Drug Development Technologies

Volumn 5, Issue 4, 2007, Pages 501-513

  Kadkhodayan Fischer, Saloumeh ^a   Elliott, Linda O ^a   Mausisa, Grace ^a   Wallweber, Heidi Ackerly ^a   Deshayes, Kurt ^a   Feng, Bainian ^a   Fairbrother, Wayne J ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLGLUTAMYLALANYLVALYLALANYLTRYPTOPHYLLYSYLSERYLGLUTAMIC ACID; ALANYLGLUTAMYLPROLYLTRYPTOPHYLISOLEUCYLGLYCYLLYSYLSERYLGLUTAMIC ACID; ALANYLISOLEUCYLPROLYLPHENYLALANYLGLUTAMYLGLUTAMYLLYSYLSERYLGLUTAMIC ACID; ALANYLTHREONYLALANYLVALYLISOLEUCYLGLUTAMYLLYSYLSERYLGLUTAMIC ACID; ALANYLVALYLPROLYLISOLEUCYLALANYLGLUTAMINYLLYSYLSERYLGLUTAMIC ACID; ALANYLVALYLPROLYLPHENYLALANYLALANYLVALYLLYSYLSERYLGLUTAMIC ACID; BUTYLOXYCARBONYLALANYLVALYLPROLYL 6 HYDROXYTRYPTAMINE; LANTHANIDE; MELANOMA INHIBITOR OF APOPTOSIS ANTAGONIST; PEPTIDE DEFORMYLASE; PROTEIN DERIVATIVE; PROTEIN PEPTIDE INTERACTION ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; CHEMOLUMINESCENCE; DRUG IDENTIFICATION; DRUG SCREENING; ELECTROCHEMICAL ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE POLARIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; IC 50; INTERMETHOD COMPARISON; PEPTIDE ANALYSIS; PROTEIN ENGINEERING; PROTEIN PROTEIN INTERACTION; REPRODUCIBILITY;

BIOLOGICAL ASSAY; BIOTIN; DATA INTERPRETATION, STATISTICAL; DRUG EVALUATION, PRECLINICAL; ESCHERICHIA COLI; FLUORESCEINS; FLUORESCENCE POLARIZATION; PEPTIDES; PROTEINS;

EID: 35148817146     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2007.070     Document Type: Article

References (22)

1. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
2. Miller AK: An exegesis of IAPs: salvation and surprises from BIR motifs. Trends Cell Biol 1999;9:323-328.
3. Fesik SW, Shi Y: Controlling the caspases. Science 2001;294:1477-1478.
4. Du C, Fang M, Li Y, Li L, Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000;102:33-42.
5. Verhagen AM, Ekert PG, Pausch M, Sikle J, Connolly LM, Reid GE, et al.: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000;102:43-53.
6. Ullman EF, Kirakossian H, Singh S, Wu ZP, Irvin BR, Pease JS, et al.: Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. Proc Natl Acad Sci U S A 1994;91:5426-5430.
7. Ullman EF, Kirakossian H, Switchenko AC, Ishkanian J, Ericson M, Wartchow CA, et al.: Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogenous immunoassay method. Clin Chem 1996;42:1518-1526.
8. Franklin MC, Kadkhodayan S, Ackerly H, Alexandru D, Distefano MD, Elliott LO, et al.: Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP). Biochemistry 2003;42:8223-8231.
9. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
10. Quench correction for LANCE™ time-resolved fluorescence resonance energy transfer [application note #1234-9860-01]. Perkin Elmer, Boston, 2002.
11. Sportsman JR, Lee SK, Dilley H, Bukar R: Fluorescence polarization. In: High Throughput Screening: The Discovery of Bioactive Substances (Devlin JP, ed.), pp. 389-399. Marcel Dekker, New York, 1997.
12. Newman M, Josiah S: Utilization of fluorescence polarization and time resolved fluorescence resonance energy transfer assay formats for SAR studies: Src kinase as a model system. J Biomol Screen 2004;9:525-532.
13. Allicotti G, Borras E, Pinilla C: A time-resolved fluorescence immunoassay (DELFIA) increases the sensitivity of antigen-driven cytokine detection. J Immunoassay Immunochem 2003;24:345-358.
14. Gribbon P, Sewing A: Fluorescence readouts in HTS: no gain without pain? Drug Discov Today 2003;8:1035-1043.
15. Xu YY: Co-fluorescence enhancement system based on pivaloyltrifloroacetone and yttrium for the simultaneous detection of europium, terbium, samarium and disposium. Anal Chim Acta 1992;256:9-16.
16. Xu YY, Pettersson K, Blomberg K, Hemmilä I, Mikola H, Lövgren T: Simultaneous quadruple-label fluorometric immunoassay of thyroid-stimulating hormone, 17 α-hydroxyprogestrone, immunoreactive trypsin, and creatine kinase MM isoenzyme in dried blood spots. Clin Chem 1992;38:2038-2043.
17. Siitari H: Dual-label time-resolved fluoroimmunoassay for the simultaneous detection of adenovirus and rotavirus in faeces. J Virol Methods 1990;28:179-188.
18. Fowler A, Swift D, Longman E, Acornley A, Hemsley P, Murray D, et al.: An evaluation of fluorescence polarization and lifetime discriminated polarization for high throughput screening of serine/threonine kinases. Anal Biochem 2002;308:223-231.
19. Banks P, Gosselin M, Prystay L: Impact of red-shifted dye label for high throughput fluorescence polarization assays of G protein-coupled receptors. J Biomol Screen 2000;5:329-334.
20. Kolb J, Yamanaka G, Manly S: Use of a novel homogeneous fluorescent technology in high throughput screeing. J Biomol Screen 1996;1:203-210.
21. Turek-Etienne TC, Small EC, Soh SC, Xin TA, Gaitonde PV, Barrabee EB, et al.: Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease, and I phosphatase. J Biomol Screen 2003;8:176-184.
22. Glickman JF, Wu X, Mercuri R, Illy C, Bowen BR, He Y, et al.: A comparison of AlphaScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors. J Biomol Screen 2002;7:3-10.